Taita Chemical Company Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Taita Chemical Company wird ein Gewinn- und Umsatzwachstum von 93.6% bzw. 9.7% pro Jahr prognostiziert, während der Gewinn pro Aktie um 94.6% pro Jahr wachsen soll.

Wichtige Informationen

93.6%

Wachstumsrate der Gewinne

94.4%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	43.3%
Wachstumsrate der Einnahmen	9.7%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	15 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Taita Chemical Company (TWSE:1309) Is Paying Out Less In Dividends Than Last Year

Jun 07

Returns On Capital Are A Standout For Taita Chemical Company (TPE:1309)

Apr 20

Is Taita Chemical Company, Ltd. (TPE:1309) A Smart Choice For Dividend Investors?

Apr 05

Taita Chemical Company's (TPE:1309) Wonderful 502% Share Price Increase Shows How Capitalism Can Build Wealth

Mar 21

Estimating The Intrinsic Value Of Taita Chemical Company, Ltd. (TPE:1309)

Mar 03

Does Taita Chemical Company (TPE:1309) Have A Healthy Balance Sheet?

Feb 10

Could The Market Be Wrong About Taita Chemical Company, Ltd. (TPE:1309) Given Its Attractive Financial Prospects?

Jan 23

Will Taita Chemical Company (TPE:1309) Become A Multi-Bagger?

Jan 06

Is There More To The Story Than Taita Chemical Company's (TPE:1309) Earnings Growth?

Dec 19

Introducing Taita Chemical Company (TPE:1309), The Stock That Soared 365% In The Last Five Years

Dec 02

Gewinn- und Umsatzwachstumsprognosen

TWSE:1309 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (TWD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	18,444	-17	N/A	2,374	1
12/31/2024	17,697	-208	N/A	-816	1
3/31/2024	15,421	-303	-933	-746	N/A
12/31/2023	15,205	-274	-425	-243	N/A
9/30/2023	14,988	-203	325	476	N/A
6/30/2023	15,695	-95	22	161	N/A
3/31/2023	17,123	81	607	764	N/A
12/31/2022	18,084	412	961	1,103	N/A
9/30/2022	19,549	905	696	852	N/A
6/30/2022	20,218	1,238	1,108	1,263	N/A
3/31/2022	20,771	1,620	976	1,113	N/A
12/31/2021	20,771	1,850	608	736	N/A
9/30/2021	20,292	2,190	1,926	2,060	N/A
6/30/2021	19,077	2,480	2,326	2,484	N/A
3/31/2021	17,076	2,264	2,463	2,595	N/A
12/31/2020	15,498	1,920	2,909	3,046	N/A
9/30/2020	14,875	1,212	2,034	2,146	N/A
6/30/2020	15,115	563	959	1,049	N/A
3/31/2020	16,030	348	1,404	1,494	N/A
12/31/2019	17,672	398	1,510	1,603	N/A
9/30/2019	18,563	140	1,173	1,288	N/A
6/30/2019	19,977	131	1,013	1,141	N/A
3/31/2019	21,442	214	294	442	N/A
12/31/2018	21,684	208	-665	-503	N/A
9/30/2018	22,060	627	-268	-112	N/A
6/30/2018	21,472	858	-19	152	N/A
3/31/2018	20,145	601	478	650	N/A
12/31/2017	19,821	502	N/A	420	N/A
9/30/2017	19,051	361	N/A	174	N/A
6/30/2017	17,704	84	N/A	579	N/A
3/31/2017	17,248	162	N/A	210	N/A
12/31/2016	16,419	121	N/A	983	N/A
9/30/2016	15,551	-6	N/A	1,260	N/A
6/30/2016	15,779	-142	N/A	1,132	N/A
3/31/2016	16,643	35	N/A	522	N/A
12/31/2015	17,028	68	N/A	1,418	N/A
9/30/2015	18,213	-136	N/A	2,112	N/A
6/30/2015	19,950	-66	N/A	2,622	N/A
3/31/2015	20,645	-336	N/A	2,771	N/A
12/31/2014	20,934	-631	N/A	-313	N/A
9/30/2014	21,247	-484	N/A	-1,364	N/A
6/30/2014	21,381	-380	N/A	-2,352	N/A
3/31/2014	21,413	-248	N/A	-1,937	N/A
12/31/2013	21,439	17	N/A	-491	N/A
9/30/2013	20,860	113	N/A	-211	N/A
6/30/2013	20,137	205	N/A	115	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 1309 wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: 1309 wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: 1309 wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: 1309Die Einnahmen des Unternehmens (9.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt TW (10.7% pro Jahr).

Hohe Wachstumseinnahmen: 1309Die Einnahmen des Unternehmens (9.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von 1309 in 3 Jahren voraussichtlich hoch sein wird

Taita Chemical Company Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates have been downgraded.

Consensus EPS estimates fall from profit to NT$0.28 loss

Consensus EPS estimates fall by 28%

Consensus forecasts updated

Consensus forecasts updated

Analysts update estimates

Recent updates

Taita Chemical Company, Limited Announces Cash Dividend for the Year 2023, Payable on August 23, 2024

Taita Chemical Company (TWSE:1309) Is Paying Out Less In Dividends Than Last Year

Dividend reduced to NT$0.30

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Taita Chemical Company, Limited to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings: EPS misses analyst expectations

Taita Chemical Company, Limited, Annual General Meeting, May 31, 2024

Taita Chemical Company, Limited Announces the Change of Accounting Officer

Consensus EPS estimates have been downgraded.

TTCTJ Announces Change of its President

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Taita Chemical Company, Limited Announces Executive Changes, Effective on September 01, 2023

Upcoming dividend of NT$0.50 per share at 2.5% yield

Taita Chemical Company, Limited Announces Demise of James Yuan, Independent Director of the Company

Taita Chemical Company, Limited Approves Dividend for the Year 2022

Consensus EPS estimates fall from profit to NT$0.28 loss

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 28%

Third quarter 2022 earnings released: EPS: NT$0.09 (vs NT$0.93 in 3Q 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$0.09 (vs NT$0.93 in 3Q 2021)

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus forecasts updated

Upcoming dividend of NT$2.00 per share

Consensus forecasts updated

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS NT$0.97 (vs NT$1.74 in 3Q 2020)

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$2.00 per share

Second quarter 2021 earnings released: EPS NT$1.57 (vs NT$0.95 in 2Q 2020)

An unknown buyer acquired 2.5% stake in Taita Chemical Company, Limited (TWSE:1309) from Taiwan Union International Investment Corp. for approximately TWD 310 million.

Director Han-Tai Liu has left the company

First quarter 2021 earnings released: EPS NT$1.42 (vs NT$0.42 in 1Q 2020)

Returns On Capital Are A Standout For Taita Chemical Company (TPE:1309)

Is Taita Chemical Company, Ltd. (TPE:1309) A Smart Choice For Dividend Investors?

Full year 2020 earnings released: EPS NT$5.58 (vs NT$1.16 in FY 2019)

Taita Chemical Company's (TPE:1309) Wonderful 502% Share Price Increase Shows How Capitalism Can Build Wealth

Investor sentiment improved over the past week

New 90-day high: NT$39.15

Taita Chemical Company, Ltd., Annual General Meeting, May 31, 2021

Estimating The Intrinsic Value Of Taita Chemical Company, Ltd. (TPE:1309)

Does Taita Chemical Company (TPE:1309) Have A Healthy Balance Sheet?

Could The Market Be Wrong About Taita Chemical Company, Ltd. (TPE:1309) Given Its Attractive Financial Prospects?

New 90-day low: NT$29.50

Analysts update estimates

Will Taita Chemical Company (TPE:1309) Become A Multi-Bagger?

New 90-day high: NT$35.15

Is There More To The Story Than Taita Chemical Company's (TPE:1309) Earnings Growth?

Introducing Taita Chemical Company (TPE:1309), The Stock That Soared 365% In The Last Five Years

Taita Chemical Company, Ltd. Appoints Wu, Pei-Chi as Director

Third quarter 2020 earnings released: EPS NT$1.91

Earnings beat expectations, revenue disappoints

Analysts update estimates

New 90-day high: NT$34.65

Market bids up stock over the past week

New 90-day high: NT$31.95

Analysts increase EPS estimates to NT$2.85

New 90-day high - NT$22.00

Analysts update estimates

First half earnings released

New 90-day high - NT$16.95

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken